Mycobacteriosis

Chapter 39 Mycobacteriosis



Mycobacteria are gram-positive organisms that cause sporadic disease in human beings and in animals. All mycobacterial organisms contain a lipid-rich cell wall that inhibits host defense mechanisms and imparts a characteristic staining property in the laboratory. This staining property involves the retention of carbolfuchsin after acid and alcohol decolorization. Thus mycobacteria are classified as acid-fast staining organisms.


Recently, a new conceptual framework for classification of mycobacterial infections of dogs and cats was proposed. This classification takes into account the mammalian host, the infecting bacteria, and the environment. Consideration of mycobacterial infections within this framework provides the clinician with important information for diagnosis, treatment, and prevention. The categories of mycobacterial diseases as they relate to skin disease specifically are as follows:






FELINE LEPROSY SYNDROMES


Feline leprosy is a mycobacterial disease of cats that was first recognized in Australia during the early 1960s. The condition has since been identified in New Zealand, Great Britain, France, the Netherlands, and the west coast of the United States and Canada. The disease is usually confined to cats living in coastal areas.


Feline leprosy refers to mycobacterial disease in which single or multiple skin granulomas are present. The granulomas contain large numbers of organisms that cannot be cultured using standard techniques. Until recently, all cases of feline leprosy were thought to be caused by M. lepraemurium and to occur in young cats. Recent studies have identified different syndromes of feline leprosy.



Feline Leprosy Caused by Mycobacterium Lepraemurium





Diagnosis












Treatment


Treatment may not be necessary when lesions are small, unobtrusive, and likely to be self-limiting. However, this strategy is seldom effective and is recommended only for lesions that appear to be resolving spontaneously at the time of diagnosis.




Clofazimine is an iminophenazine dye with antimycobacterial properties that is suspended in olive oil and packaged in 50- and 100-mg capsules. Although the pharmacokinetics of clofazimine in the cat are unknown, a dosage of 10 mg/kg once daily PO (25–50 mg every 1–2 days), for 6 to 12 weeks past complete clinical resolution appears to be very effective. Wear latex gloves to prevent staining of hands. Clofazimine is not approved by the U.S. Food and Drug Administration (FDA) for animal use.


Stay updated, free articles. Join our Telegram channel

Aug 27, 2016 | Posted by in SMALL ANIMAL | Comments Off on Mycobacteriosis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access